PT-141 vs Melanotan II: Sexual Health & Tanning Peptide Comparison
PT-141
Sexual HealthPT-141 (Bremelanotide) is a melanocortin receptor agonist that acts centrally on the nervous system to enhance sexual arousal. Unlike PDE5 inhibitors, it works through neural pathways rather than vascular mechanisms.
View full profile →Melanotan II
TanningMelanotan II is a synthetic analogue of alpha-melanocyte-stimulating hormone (α-MSH). It stimulates melanin production in the skin, producing a tan without UV exposure, while also having effects on libido and appetite.
View full profile →Comparison Overview
PT-141 (Bremelanotide) and Melanotan II share a fascinating history—PT-141 was actually developed from Melanotan II after researchers discovered its potent effects on sexual arousal during tanning studies. Both are melanocortin receptor agonists, but they differ significantly in selectivity. PT-141 primarily targets MC3R and MC4R receptors involved in sexual function, while Melanotan II is non-selective and activates MC1R through MC5R, producing tanning, sexual, and appetite effects simultaneously.
PT-141 is the more refined compound for sexual health research. It received FDA approval in 2019 as Vyleesi for hypoactive sexual desire disorder (HSDD) in premenopausal women, making it the only peptide in this comparison with a current FDA-approved indication for sexual function. Its mechanism works centrally through the brain's arousal pathways rather than through vascular mechanisms like PDE5 inhibitors.
Melanotan II remains popular in research circles for its multi-functional profile. Its MC1R activation stimulates melanin production (tanning without UV exposure), while its MC3R/MC4R activation produces sexual arousal effects similar to PT-141. However, this non-selectivity also means more potential side effects, including nausea, facial flushing, and changes to existing moles that require monitoring.
Key Differences
| Category | PT-141 | Melanotan II |
|---|---|---|
| Receptor Selectivity | Selective for MC3R and MC4R (sexual function) | Non-selective, activates MC1R through MC5R |
| Primary Use | Sexual arousal and libido enhancement | Skin tanning with secondary sexual/appetite effects |
| FDA Status | FDA-approved as Vyleesi for HSDD (2019) | No FDA approval |
| Tanning Effect | Minimal to no tanning effect | Significant melanin stimulation and tanning |
| Side Effect Profile | Nausea, flushing, headache (more targeted) | Nausea, flushing, mole changes, appetite suppression (broader) |
| Development History | Derived from Melanotan II, refined for sexual function | Original compound from which PT-141 was developed |
Overlapping Research Areas
- Sexual health research
- Libido studies
- Melanocortin receptor research
- Appetite regulation studies
Which One to Research?
Researchers focused specifically on sexual function typically prefer PT-141 for its greater selectivity and FDA-backed safety data. Those interested in tanning effects, or studying the broader melanocortin system including appetite and pigmentation, may find Melanotan II more relevant. PT-141's targeted profile generally means fewer off-target effects compared to Melanotan II's broader receptor activation.
⚠️ Important: This comparison is for informational and educational purposes only. It does not constitute medical advice. Consult a qualified healthcare professional before making any decisions regarding peptide use.
Learn More in the Peptide Playbook
Get comprehensive protocols, dosing information, and vendor selection guidance.
Get the Full Guide →